medicine: entacapone

entacapone description

Go to trade names and prices








Entacapone (INN) (pronounced /ˌɛntəkəˈpoʊn/, /ɛnˈtækəpoʊn/) is a drug that functions as a catechol-O-methyl transferase (COMT) inhibitor. It is used in the treatment of Parkinson's disease.

When administered in conjunction with dopaminergic agents such as L-DOPA, entacapone prevents COMT from metabolizing L-DOPA into 3-methoxy-4-hydroxy-L-phenylalanine (3-OMD) in the periphery, which does not easily cross the blood brain barrier (BBB). Pharmacologically, entacapone is somewhat similar to carbidopa or benserazide, in that it is an inhibitor of an enzyme that converts L-DOPA into a compound that cannot cross the BBB. carbidopa and beserazide inhibit aromatic L-amino acid decarboxylase, which converts L-DOPA into dopamine, which cannot cross the BBB.

Entacapone is a member of the class of drugs known as nitrocatechols.

The most frequent undesirable effects caused by entacapone relate to the increased effects of L-DOPA, such as involuntary movements (dyskinesias). These occur most frequently at the beginning of entacapone treatment. Others common side effects are gastrointestinal problems, including diarrhoea, nausea and abdominal pains. The substance may cause urine to turn reddish-brown. This is a harmless side effect and is not a cause for concern. In studies with entacapone, some people have reported experiencing a dry mouth.

Products

Entacapone is developed by Orion Pharma and marketed by Novartis under the trade name comtan in the United States.

Stalevo is another Novartis medication that contains entacapone in combination with carbidopa and levodopa (active ingredients in Sinemet).

Trade names

Trade names and prices of entacapone

Name Information Price* Quantity
       
Generic Carbidopa/Entacapone/Levodopa 12.5mg/200mg/50mg 50 tablet $70 50 tablet
Generic Carbidopa/Entacapone/Levodopa 25mg/200mg/100mg 50 tablet $70 50 tablet
Generic Carbidopa/Entacapone/Levodopa 37.5mg/200mg/150mg 50 tablet $78 50 tablet
Comtan 200mg 100 tablets (entacapone) $140 100 tablets
Generic Entacapone 200mg 50 tablet $55 50 tablet
Stalevo 12.5mg/200mg/50mg 100 tablets (carbidopa/entacapone/levodopa) $179 100 tablets
Stalevo 100 25mg/200mg/100mg 100 tablets (carbidopa/entacapone/levodopa) $179 100 tablets
Stalevo 125 31.25mg/200mg/125mg 100 tablets (carbidopa/entacapone/levodopa) $179 100 tablets
Stalevo 150 37.5mg/200mg/150mg 100 tablets (carbidopa/entacapone/levodopa) $200 100 tablets
Stalevo 200 200mg/50mg/200mg 100 tablet (carbidopa, entacapone, levodopa) $237 100 tablet
Stalevo 75 18.75mg/200mg/75mg 100 tablets (carbidopa/entacapone/levodopa) $179 100 tablets

*) Prices related to some of online drugstores. There are only approximate prices. For some of drugs is needed a prescription.

Tags

Keywords related to entacapone

etanercept mivazerol trimetaphan camsilate ximelagatran meclofenamic acid benznidazole lithobid dtpa etrafon fampridine altumomab hexamine dinitolmide tetrahydrobiopterin duvoid carpronium chloride valaciclovir nysert azaprocin darifenacin carboplatin cyclobarbital rufinamide stavudine moexipril levophed diisopromine aldactone hexapropymate batimastat tirapazamine sodium dehydrocholate oseltamivir levodopa insulin glargine cefalexin antizol targretin intal selegiline emedastine chlorphentermine arotinolol calcium channel blocker sabcomeline poloxamer


  • Related news


    Positive Primary Endpoint from FIRST-STEP Study with Stalevo in Early
    ABOUT STALEVO Stalevo (levodopa/carbidopa/entacapone) is an enhanced levodopa therapy for the treatment of Parkinson's Disease indicated for those patients ...
    Read full article

    Finland pharma: Orion files suit blocking generic Stalevo
    of Orion's proprietary Parkinson's drug, Stalevo (25/200/100mg, 37.5/200/150mg, and 50/200/200mg strengths of carbidopa/entacapone/levodopa) in the USA. ...
    Read full article

    Restless Leg Syndrome Medications - Restless Leg Syndrome Health
    Adding a drug called entacapone (Comtan) may prolong the duration of action of carbidopa-levodopa therapy (Sinemet), but it can cause nausea. ...
    Read full article

    Modern treatment for Parkinson's disease improves the well-being and
    Stalevo(*), a combination of levodopa, carbidopa and entacapone, is indicated in the treatment of adult patients suffering from idiopathic Parkinson's ...
    Read full article

    Press Release: Early Administration of Aggrenox(R) is Effective and
    the optimised levodopa medication Stalevo - containing levodopa, carbidopa and entacapone - delays the onset of motor complications ...
    Read full article

    Press Release: Schering-Plough Reports Preladenant Meets Primary
    All patients were on a stable regimen of standard treatments with L-DOPA and other adjunctive treatments, such as dopamine agonists and/or entacapone, ...
    Read full article

    Finnish Orion files US lawsuit to protect key drug
    "Comtan contains entacapone and is a product originated by Orion Corporation and marketed in the United States for the treatment of Parkinson's disease by ...
    Read full article

    Schering Plough Reports Preladenant Meets Primary Endpoint In Phase
    All patients were on a stable regimen of standard treatments with L-DOPA and other adjunctive treatments, such as dopamine agonists and/or entacapone, ...
    Read full article

    Orion comments on new challenge by Sun Pharmaceutical Industries
    strengths of carbidopa/levodopa/entacapone) in the United States. Sun's amendment to its ANDA involves a Paragraph IV challenge to Orion's US Patent No. ...
    Read full article

    Existing Parkinson's Disease Drug May Fight Drug-Resistant TB
    But existing drugs are highly toxic and of completely different chemical structure than entacapone and tolcapone. Here we have drugs that are known to be ...
    Read full article

    Dancing, not falling.(INDICATIONS)(Brief article) Article from
    Entacapone and rasagiline are effective in reducing off time in PD patients receiving dopaminergic therapy. Pramipexole, ropinirole has the best ...
    Read full article

    Orion/Novartis' Stalevo fares well in Ph III trial.(Medical condition
    The aim of the trial was to determine whether treatment with Stalevo (carbidopa, levodopa and entacapone) provides better symptomatic benefit than the ...
    Read full article

    Parkinson's Disease Market analysis and forecasts, 2008- 2012, 2017 &
    Comtess (Entacapone) To Aid PD Treatment. 3.7. Dopamine And COMT Combined Comtan (Entacapone) Leading COMT. Inhibitors Captures Tasmar's Market Share ...
    Read full article

    Anti-Parkinson drugs
    Also in an effort to increase dopamine levels, drugs such as tolcapone and entacapone have been developed that inhibit the enzymatic breakdown of the ...
    Read full article

    Vernalis: Revised R&D Focus After Frova Decision Hits Home
    dopaminergic market full of cheap levodopa generics and Novartis's recently launched triple-combination product Stalevo (carbidopa-levodopa-entacapone). ...
    Read full article

    FINAL TRANSCRIPT
    Also, in the entacapone product mix there are change you see. Our deliveries to Novartis, of course, generates for us a clearly ...
    Read full article

    Orion in patent row with Sun
    Comtan contains entacapone, a product developed by Orion and marketed in the US by its exclusive licensee, Novartis [Get Quote]. ...
    Read full article

    Focus on the World Alzheimer's and Parkinson's Disease Market
    COMT Inhibitors II-31 Tolcapone (Tasmar) II-31 Entacapone (Comtan) II-32 MAO-B Inhibitors II-32 Dopamine Amplifiers II-32 Anticholinergics II-32 7. ...
    Read full article

    Levodopa medications for Parkinson's disease
    A catechol O-methyltransferase (COMT) inhibitor (such as entacapone), Stalevo, a new medicine that combines entacapone, levodopa, and carbidopa. ...
    Read full article

    Parkinson's Disease Candidate Meets Primary Endpoint
    The patients received three daily doses of Stalevo (levodopa/carbidopa/entacapone) or levodopa/carbidopa for nine months. ...
    Read full article

    Parkinson's drugs show promise in resistant TB
    N), and entacapone or Comtan made by Novartis AG (NOVN.VX) have the potential to treat multiple-drug-resistant and extensively drug-resistant strains of TB. ...
    Read full article

    Ask the doctors.(Column) Article from Heart Advisor HighBeam
    The COMT inhibitors tolcapone and entacapone are other new additions. Is there an age limit for valve replacement? I am 79 and have a leaky aortic valve, ...
    Read full article

    Wockhardt settles patent issue with Orion Corp
    Stalevo is a combination of carbidopa, levodopa and entacapone for the treatment of Both products contain entacapone, a COMT enzyme-inhibiting agent. ...
    Read full article

    Article: PATIO PAELLA ; SAFFRON-RICE DISH PERFECT FOR GET-
    Article: WIPO: Inventors in Spain Develop Entacapone Preparation US Fed News Service, Including US State News; November 29, 2008 ; 423 words . ...
    Read full article

    Orion Corporation Withdraws Its Application For An Extension Of
    its application for an extension of indication for the centrally authorised medicine Stalevo (levodopa/carbidopa/entacapone) film-coated tablets. ...
    Read full article

    Orion Profit Falls Short of Estimates as Costs Rise
    The patent on entacapone expires in 2013 in the US and in 2012 in Europe, according to an Orion presentation in November 2007. ...
    Read full article

    Adding Entacapone Enhances Levodopa/Carbidopa Benefit in
    By Jill Stein. CHICAGO -- April 15, 2008 -- Levodopa/carbidopa/entacapone (LCE) improves symptoms of early Parkinson's disease more than does conventional ...
    Read full article

    Entacapone blunts cravings in marijuana users.(ADDICITION
    Entacapone blunts cravings in marijuana users.(ADDICITION PSYCHIATRY) find Clinical Psychiatry News articles. BOCA RATON, FLA.--In an open-label pilot ...
    Read full article

    Orion Q4 profit misses consensus, shares down
    The drugmaker's key patent on entacapone, on which the company's two best-selling Parkinson's disease drugs, Stalevo and Comtess/Comtan, are based, ...
    Read full article

    Novartis study shows Parkinson's drug controls symptoms more than
    Stalevo is a levodopa therapy combining levodopa and carbidopa with the enzyme inhibitor entacapone, which extends the presence of levodopa in the ...
    Read full article

    Federal Register 2009 - 74 FR 27148 Final Guidances for Industry
    Estradiol Duloxetine HCl Dutasteride E Efavirenz (multiple dosage forms) Emtricitabine Entacapone Entecavir Eplerenone Erlotinib HCl Escitalopram ...
    Read full article

    COMT inhibitors for Parkinson's disease
    Doctors are also now starting to prescribe entacapone and levodopa more This warning and legal requirement does not apply to entacapone (Comtan) or ...
    Read full article

    Press Release: In Vitro Study of Adamas Pharmaceuticals' Triple
    Triple Combination Therapy Concept Utilizes Entacapone PD) in one tablet. The new triple combination therapy option will contain Orion with the ...
    Read full article

    Orion Corporation (FI) - Orion clarifies information emanating from
    As previously announced, companies of two Groups have submitted ANDAs that challenge the US entacapone basic patent no 5446194, which expires on 19 October ...
    Read full article

    Vt. psychiatrists unduly influenced.(POLICY & PRACTICE) Article
    Clinical Psychiatry News; September 1, 2007 ; 608 words entacapone) is now approved in a higher 200-mg dose indicated to help minimize the end of ...
    Read full article

    Federal Register 2009 - 74 FR 27146 Draft and Revised Draft Guidances
    A Alprazolam C Candesartan Cilexetil; Hydrochlorothiazide Carbidopa; Entacapone; Levodopa Clopidogrel Bisulfate F Fexofenadine HCl (multiple dosage forms) ...
    Read full article

    Stalevo - Levodopa / Carbidopa / Entacapone - Medical Drug
    Information can be viewed within medical specific areas. Click a medical specialty to view information relating to only that area. ...
    Read full article

    Two New Dosage Strengths Of Stalevo(R) Approved In The US Provide
    Novartis Pharmaceuticals Corporation today announced the launch of two new FDA-approved dosage strengths of Stalevo(R) (carbidopa, levodopa and entacapone), ...
    Read full article

    Also In Global Health News: Potential New Drug-Resistant TB Treatment;
    Researchers said "computer models and lab experiments suggest the drugs tolcapone or Tasmar made by Valeant Pharmaceuticals, and entacapone or Comtan made ...
    Read full article

    Orion clarifies information emanating from Capital Markets Day
    As previously announced, companies of two Groups have submitted ANDAs that challenge the US entacapone basic patent no 5446194, which expires on 19 October ...
    Read full article

    Parkinson's medicine in patent tangle
    Orion had previously sued Wockhardt for challenging the patents on Comtan (entacapone), another version of Parkinson's disease drug marketed by Novartis. ...
    Read full article

    Orion files suit against Wockhardt
    The challenge is specifically for 12.5, 200, 50-mg strength of the drug, which is a combination of three drugs carbidopa, entacapone and levodopa. ...
    Read full article

    Novartis Pharma Ag - Company Snapshot - AlacraStore.com
    Stalevo ### mg (## mg carbidopa, ### mg levodopa, ### mg entacapone) provides for greater dosing Class action suit targets Novartis. ...
    Read full article

    Parkinson's Disease Treatment - Parkinson's Disease Health Information
    Entacapone (Comtan) belongs to a class of drugs called catechol-o-methyl transferase (COMT) inhibitors. COMT inhibitors help prolong the effects of levodopa ...
    Read full article